Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AngioScore closes its $30mm Series D venture round

Executive Summary

AngioScore (angioplasty catheters) has raised $30mm with its Series D venture round. Telegraph Hill Partners led the round and was joined by other new investor QuestMark Partners and current institutional backers Psilos Group Management, UV Partners, California Technology Ventures, and InnoMed Ventures. Members of Telegraph Hill Partners and QuestMark Partners joined AngioScore's board of directors.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies